Sedana Medical AB (publ)
STO:SEDANA

Watchlist Manager
Sedana Medical AB (publ) Logo
Sedana Medical AB (publ)
STO:SEDANA
Watchlist
Price: 12.14 SEK -1.62% Market Closed
Market Cap: 1.2B SEK

Wall Street
Price Targets

SEDANA Price Targets Summary
Sedana Medical AB (publ)

Wall Street analysts forecast SEDANA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SEDANA is 24.48 SEK with a low forecast of 24.24 SEK and a high forecast of 25.2 SEK.

Lowest
Price Target
24.24 SEK
100% Upside
Average
Price Target
24.48 SEK
102% Upside
Highest
Price Target
25.2 SEK
108% Upside
Sedana Medical AB (publ) Competitors:
Price Targets
CBLL
CeriBell Inc
84% Upside
GMED
Globus Medical Inc
46% Upside
EUZ
Eckert & Ziegler Strahlen und Medizintechnik AG
6% Upside
NPCE
Neuropace Inc
34% Upside
IDXX
IDEXX Laboratories Inc
0% Upside
7817
Paramount Bed Holdings Co Ltd
3% Upside
SIBN
SI-BONE Inc
33% Upside
ELN
El En SpA
17% Upside

Revenue
Forecast

Revenue Estimate
Sedana Medical AB (publ)

For the last 8 years the compound annual growth rate for Sedana Medical AB (publ)'s revenue is 24%. The projected CAGR for the next 3 years is 30%.

24%
Past Growth
30%
Estimated Growth
Estimates Accuracy
1%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Sedana Medical AB (publ)

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

Net Income Estimate
Sedana Medical AB (publ)

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-16%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SEDANA's stock price target?
Price Target
24.48 SEK

According to Wall Street analysts, the average 1-year price target for SEDANA is 24.48 SEK with a low forecast of 24.24 SEK and a high forecast of 25.2 SEK.

What is Sedana Medical AB (publ)'s Revenue forecast?
Projected CAGR
30%

For the last 8 years the compound annual growth rate for Sedana Medical AB (publ)'s revenue is 24%. The projected CAGR for the next 3 years is 30%.

Back to Top